Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes

OBJECTIVE: Diabetes has emerged as an important risk factor for mortality from COVID-19. Metformin, the most commonly prescribed glucose-lowering agent, has been proposed to influence susceptibility to and outcomes of COVID-19 via multiple mechanisms. We investigated whether, in patients with diabet...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Endocrinol Metab
Main Authors: Wang, Jingya, Cooper, Jennifer M, Gokhale, Krishna, Acosta-Mena, Dionisio, Dhalla, Samir, Byne, Nathan, Chandan, Joht Singh, Anand, Astha, Okoth, Kelvin, Subramanian, Anuradhaa, Bangash, Mansoor N, Jackson, Thomas, Zemedikun, Dawit, Taverner, Tom, Hanif, Wasim, Ghosh, Sandip, Narendran, Parth, Toulis, Konstantinos A, Tahrani, Abd A, Surenthirakumaran, Rajendra, Adderley, Nicola J, Haroon, Shamil, Khunti, Kamlesh, Sainsbury, Christopher, Thomas, G Neil, Nirantharakumar, Krishnarajah
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2021
Assuntos:
Clinical Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7928949/
https://ncbi.nlm.nih.gov/pubmed/33560344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgab067
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares